Biotech

All Articles

Innovent web links cytokine to colon cancer responses

.Innovent Biologics has actually helped make the scenario that its checkpoint inhibitor-cytokine ble...

Merck, Daiichi ADC reaches objective in phase 3 lung cancer research study

.A period 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugat...

Rakovina strengthens artificial intelligence concentrate with collab to select cancer targets

.5 months after Rakovina Therapeutics rotated towards artificial intelligence, the cancer-focused bi...

Ascendis' dwarfism medication hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually become a potential hazard to BioMarin's Voxzogo, reporting phase 3 gro...

Despite ph. 3 miss, Alkeus finds pathway in advance for eye disease property

.Though Alkeus Pharmaceuticals' dental eye disease possession failed to substantially lessen geograp...

Kairos goes public with $6M IPO to fund tests of cancer medicine

.With a trio of biotechs attacking the Nasdaq on Friday, it was simple to miss out on a smaller-scal...

Vaccine as well as Keytruda combination reliable in squamous cell cancer

.Invulnerable checkpoint preventions are actually the superheroes of cancer cells treatment. Medicin...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and...

Regeneron's Opdualag competitor presents 57% reaction fee

.Regeneron is back along with long-term follow-up for its own LAG-3 prevention and PD-1 inhibitor co...

AstraZeneca blog posts information on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early examine the performance of its internal antibody-dr...